RxDoctor Payments Data

Bruce Mather, MD

Family Medicine · Mooresville, NCNPI 1053399071

Payments from drug & device makers

$12,759in general payments, 2019–2025

Across 786 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$1K
  • Pfizer$1K
  • AbbVie$1K
  • Amgen$813
  • GSK$730
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$12,747100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk128$1,725
AstraZeneca44$1,209
Pfizer75$1,119
AbbVie(2 entities)72$1,075
Amgen56$813
GSK41$730
Lilly USA, LLC41$579
Boehringer Ingelheim34$557
Bayer29$464
Novartis21$332
Esperion Therapeutics, Inc.11$279
Astellas Pharma US Inc11$245
Johnson & Johnson14$231
Abbott10$223
Amarin Pharma, Inc.15$220
Kowa Pharmaceuticals America, Inc.17$218
Sumitomo Pharma America, Inc.10$205
Sanofi-aventis U.S. LLC8$156
Eisai Inc.11$150
Merck10$148
Takeda Pharmaceuticals U.S.A., Inc.9$140
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC9$126
Idorsia Pharmaceuticals US Inc8$125
Daiichi Sankyo Inc.6$111
Lundbeck LLC5$108
Teva Pharmaceuticals USA, Inc.6$88
Ironwood Pharmaceuticals, Inc5$84
Neos Therapeutics, LP6$83
Cranial Technologies, Inc5$82
Biohaven Pharmaceuticals, Inc.5$72
Heartflow, Inc.1$68
E.r. Squibb & Sons, L.L.C.5$67
Avion Pharmaceuticals4$60
Amneal Pharmaceuticals LLC3$53
Biohaven Pharmaceutical Holding Company Ltd.3$49
IBSA Pharma Inc.3$48
Axsome Therapeutics, Inc.2$43
Exact Sciences2$42
Dexcom, Inc.2$41
Otsuka America Pharmaceutical, Inc.2$38
Almatica Pharma LLC3$35
Phathom Pharmaceuticals, Inc.3$33
Inspire Medical Systems, Inc.1$32
Arbor Pharmaceuticals, Inc.2$30
Sanofi Pasteur Inc.2$30
Tris Pharma Inc2$27
Ironshore Pharmaceuticals Inc.2$25
Verity Pharmaceuticals Inc.1$24
Supernus Pharmaceuticals, Inc.1$24
Corcept Therapeutics1$23
Abiomed1$22
Organon1$19
Phadia US Inc.1$19
Adlon Therapeutics L.p.1$17
Bausch Health US, LLC1$15
Braintree Laboratories, Inc.1$14
SK Life Science, Inc.1$14
Hologic Sales And Service, LLC1$14
Shire North American Group Inc1$14
Kaleo, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,759 in reported general payments places this provider in the 95th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$206,007
Medicare patients
381
Services billed
3,316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide132$167,953
JardianceEmpagliflozin62$78,778
RybelsusSemaglutide32$66,750
FarxigaDapagliflozin Propanediol33$48,109
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$46,623
EliquisApixaban33$40,193
TrulicityDulaglutide19$33,954
MounjaroTirzepatide28$30,060
Repatha SureclickEvolocumab33$21,425
XareltoRivaroxaban17$19,161
MyrbetriqMirabegron19$16,721
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$15,283
JanuviaSitagliptin Phosphate21$14,611
VascepaIcosapent Ethyl16$11,902
Repatha SyringeEvolocumab21$11,526

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,725$234,703164 claims
Boehringer IngelheimJardiance$557$78,77862 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,209$66,83969 claims
Lilly USA, LLCTrulicity, Mounjaro$579$64,01547 claims
GSKTrelegy Ellipta, Breo Ellipta$730$50,41552 claims
PfizerEliquis$1,119$40,19333 claims
Johnson & JohnsonXarelto$231$19,16117 claims
Astellas Pharma US IncMyrbetriq$245$16,72119 claims
MerckJanuvia$148$14,61121 claims
AbbVieSynthroid$1,075$4,35747 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$53$2,326312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Mooresville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →